PD1/PD-L1 is often overexpressed in cervical cancer, particularly in advanced or metastatic stages, which helps the cancer cells evade immune surveillance by inhibiting anti-tumor T-cell activity. The gene discussed is CD274; the disease is cervical carcinoma.